Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

Date: 27-10-2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Listing Department Bandra Kurla Complex, Dalal Street, Bandra East, Mumbai-400051 Mumbai-400001 Scrip Code: MUKKA Scrip Code: 544135 Dear Sir/Madam, Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In terms of Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that Mukka Proteins Limited (“the Company”) has received a Certificate of Registration issued by Registrar Corp, Virginia, USA confirming the registration of the Company’s facility with the U.S. Food and Drug Administration (U.S. FDA) pursuant to the Federal Food Drug and Cosmetic Act, as amended by the Bioterrorism Act of 2002 and the FDA Food Safety Modernization Act. The registration is expected to support the Company's business operations and facilitate its engagement with customers and markets requiring U.S. FDA facility registration. The detailed disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, is enclosed as Annexure-A. This is for your information and records. Thanking you, For Mukka Proteins Limited Mehaboobsab Mahmadgous Chalyal Company Secretary & Compliance Officer Membership No.: A67502 Encl: as above. Annexure – A Sr. No. Particulars Details 1. Name of the regulatory or U.S. Food and Drug Administration (U.S. FDA). The licensing authority certificate confirming registration has been issued by Registrar Corp, Virginia, USA. 2. Brief details of the The Company has received a Certificate of Registration approval/license obtained/ issued by Registrar Corp, Virginia, USA confirming the withdrawn/ surrendered registration of the Company’s facility with the U.S. Food and Drug Administration pursuant to the Federal Food Drug and Cosmetic Act, as amended by the Bioterrorism Act of 2002 and the FDA Food Safety Modernization Act. 3. Impact/relevance of such The US FDA registration is expected to support the Company's approval/license to the business operations and facilitate its engagement with listed entity customers and markets requiring U.S. FDA facility registration. 4. Withdrawal/cancellation or Not Applicable suspension of licence/approval by the regulatory or licensing authority, with reasons for such action, estimated impact and penalty, if any 5. Period for which such The Certificate is valid from the date of issuance, i.e. October approval/license is/was 1, 2026, until December 31, 2027. valid 6. The actual impact Not Applicable (monetary or otherwise) along with corrective actions taken by the listed entity pursuant to the withdrawal, cancellation or suspension of the key license/ approval